A GP130-Targeting Small Molecule, LMT-28, Reduces LPS-Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling

Table 1

The blood glucose of SD rats before and after 1% STZ injection (mmol/L).

Time (d)	Mean	SD	Min	Max	Test value
0	8.52	0.79	7.1	9.8
3	23.71	3.01	19.3	29.2
7	23.71	3.11	19.1	29.5
14	23.82	3.32	18.8	29.0